701 Lee Road
Wayne, PA 19087
Paul Dick, Vice President of Business Development – PDick@Inclinica.com
Our mission is to apply our in-depth experience and expertise in clinical research and drug development to lead our clients’ compounds and devices toward regulatory approval. InClinica is a global clinical CRO that specializes in leading companies through clinical trials. The company was founded in 2016 through the acquisition of an existing global clinical CRO.
Our senior leadership team brings a wealth of experience in drug development and clinical trial management. Our clinical managers have worked at large CROs and pharmaceutical companies. And, with access to world-class experts who are critical to trial design and execution, we put our experience to work for you.
Our collective experience in drug development is extensive enough to anticipate the common and not so common mistakes, oversights and assumptions that derail studies, in order to keep your program on track. We have experience in multiple diseases and device technologies, conducted across all stages of clinical trials, in North America, Asia/Pacific, Europe and Latin America.
InClinica has experience across all phases of clinical development, with particular strength assisting small to mid-sized companies that are entering first-in-human trials and phase II studies. Our talents, combining late drug discovery and early development experience, make us unique among other clinical CROs and provide significant value to companies in these early clinical phases. Does that mean we can’t do phase III studies? Hardly. We have — and we are.
We bring deep experience in oncology, metabolic disease, and inflammatory diseases, along with experience in diseases as diverse as cardiovascular disease, GI disorders, and infectious disease.